Assignee
CURASEN THERAPEUTICS INC
US·6 granted patents·14 pending applications·8 citations·filing 2019–2023
Top patents by PatentIndex Score
20 records- 0191US11607395B2Methods for improving neurological diseases and disordersCURASEN THERAPEUTICS INC·Filed 2020·Granted Mar 21, 2023·4 cites·26 claims
- 0290US10947196B2Beta adrenergic agonist and methods of using the sameCURASEN THERAPEUTICS INC·Filed 2020·Granted Mar 16, 2021·2 cites·6 claims
- 0385US11590107B2Methods for treating neurological disorders with α1A-AR partial agonistsCURASEN THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·1 cites·28 claims
- 0483US11040944B2Beta adrenergic agonist and methods of using the sameCURASEN THERAPEUTICS INC·Filed 2020·Granted Jun 22, 2021·1 cites·20 claims
- 0572US12558325B2Methods for improving neurological diseases and disordersCURASEN THERAPEUTICS INC·Filed 2023·Granted Feb 24, 2026·0 cites·23 claims
- 0672US2023414588A1Compositions and methods for treating patients with amyotrophic lateral sclerosis (als)CURASEN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0772US2021371380A1Beta adrenergic agonist and methods of using the sameCURASEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0872US2025134835A1Compositions and methods for treating patients with amyotrophic lateral sclerosis (als)CURASEN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0970US12448352B2Beta adrenergic agonist and methods of using the sameCURASEN THERAPEUTICS INC·Filed 2020·Granted Oct 21, 2025·0 cites·20 claims
- 1062US2025188060A1Alpha1a-adrenergic receptor agonists and methods of useCURASEN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1161US2021121445A1METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH a1A-AR PARTIAL AGONISTSCURASEN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1259US2024270701A1Beta adrenergic agonist and methods of using the sameCURASEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1356US2024352002A1Beta adrenergic agonist and methods of using the sameCURASEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1456US2023312524A1Alpha1a-adrenergic receptor agonists and methods of useCURASEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1554US2023219892A1Forms and compositions of a beta adrenergic agonistCURASEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1654US2023157974A1Compositions and methods for improving neurological diseases and disordersCURASEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1751US2022315534A1Beta adrenergic agonist and methods of using the sameCURASEN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1849US2023263749A1Compositions and methods for improving neurological diseases and disordersCURASEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1945US2021251923A1Methods for improving neurological diseases and disordersCURASEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2045US2021251559A1Methods for diagnosing, monitoring and treating neurological diseases and disordersCURASEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →